首页 News 正文

According to the website of the United States Senate, the Senate will hold a hearing on September 24 local time to examine whether Novo Nordisk provides overpriced smeglutide products Ozempic and Wegovy for patients with diabetes and obesity.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

王俊杰2017 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    28